BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 6799816)

  • 41. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bacterial-mammalian mutagenesis correlations: mechanistic significance for carcinogenesis.
    Bartsch H
    Ann N Y Acad Sci; 1983; 407():351-61. PubMed ID: 6576679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Further studies on the detection of mutagenic and genotoxic activity in human faeces: aerobic and anaerobic fluctuation tests with S. typhimurium and E. coli, and the SOS Chromotest.
    Venitt S; Bosworth D
    Mutagenesis; 1986 Jan; 1(1):49-64. PubMed ID: 3325736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper No. 5. Genotoxicity tests as predictors of carcinogens: an analysis.
    Douglas GR; Blakey DH; Clayson DB
    Mutat Res; 1988 Jul; 196(1):83-93. PubMed ID: 3292901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacterial photomutagenicity testing: distinction between direct, enzyme-mediated and light-induced events.
    Utesch D; Splittgerber J
    Mutat Res; 1996 Sep; 361(1):41-8. PubMed ID: 8816942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM Workshop.
    Kirkland D; Zeiger E; Madia F; Gooderham N; Kasper P; Lynch A; Morita T; Ouedraogo G; Parra Morte JM; Pfuhler S; Rogiers V; Schulz M; Thybaud V; van Benthem J; Vanparys P; Worth A; Corvi R
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Dec; 775-776():55-68. PubMed ID: 25435356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.
    Vogel EW; Barbin A; Nivard MJ; Stack HF; Waters MD; Lohman PH
    Mutat Res; 1998 May; 400(1-2):509-40. PubMed ID: 9685708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion.
    McCann J; Ames BN
    Proc Natl Acad Sci U S A; 1976 Mar; 73(3):950-4. PubMed ID: 768988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutagenicity and carcinogenicity correlations between bacteria and rodents.
    Brusick D
    Ann N Y Acad Sci; 1983; 407():164-76. PubMed ID: 6349473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationships between structures and mutagenic potencies of 16 heterocyclic nitrogen mustards (ICR compounds) in Salmonella typhimurium.
    DeMarini DM; Pham HN; Katz AJ; Brockman HE
    Mutat Res; 1984 Jun; 136(3):185-99. PubMed ID: 6204200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the DNA repair host-mediated assay. II. Presence of genotoxic factors in various organs of mice treated with chemotherapeutic agents.
    Kerklaan PR; Bouter S; van Elburg PE; Mohn GR
    Mutat Res; 1986 Feb; 164(1):19-29. PubMed ID: 2419750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ; Shane BS; Tindall KR; Cunningham ML
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative relationship between mutagenic potency in the Ara test of Salmonella typhimurium and carcinogenic potency in rodents. A study of 11 direct-acting monofunctional alkylating agents.
    Roldán-Arjona T; Luque-Romero FL; Ruiz-Rubio M; Pueyo C
    Carcinogenesis; 1990 Jun; 11(6):975-80. PubMed ID: 2189599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The potential applications of SOS-lux biosensors for rapid screening of mutagenic chemicals.
    Alhadrami HA; Paton GI
    FEMS Microbiol Lett; 2013 Jul; 344(1):69-76. PubMed ID: 23581454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of mutations in bacteria and of DNA damage and amplified DNA sequences in mammalian cells as a systematic test strategy for elucidating biological activities of chemical carcinogens.
    Pool BL; Eisenbrand G; Preussmann R; Schlehofer JR; Schmezer P; Weber H; Wiessler M
    Food Chem Toxicol; 1986; 24(6-7):685-91. PubMed ID: 3536693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SOS-inducing activity of chemical carcinogens and mutagens in Salmonella typhimurium TA1535/pSK1002: examination with 151 chemicals.
    Nakamura SI; Oda Y; Shimada T; Oki I; Sugimoto K
    Mutat Res; 1987 Dec; 192(4):239-46. PubMed ID: 3317033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cooperative programme on short-term assays for carcinogenicity in Japan.
    Kawachi T; Yahagi T; Kada T; Tazima Y; Ishidate M; Sasaki M; Sugiyama T
    IARC Sci Publ; 1980; (27):323-30. PubMed ID: 6777298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.